Calvatic acid

Calvatic acid
Product Name Calvatic acid
CAS No.: 54723-08-9
Catalog No.: CFN70407
Molecular Formula: C8H5N3O3
Molecular Weight: 191.1 g/mol
Purity: >=98%
Type of Compound: Miscellaneous
Physical Desc.: Powder
Targets: Antifection
Source: From Lasiosphaera seu Calvatia
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Price:
Calvatic acid is a new antibiotic with both a carboxylic group and an azoxy function in the benzene ring. It shows antimicrotubular effect.
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • Journal of Herbal Medicine2024, 48:100950
  • Journal of functional foods2018, 171-182
  • Front Microbiol.2022, 13:835463.
  • Pharmaceutics.2021, 13(7):1028.
  • Antioxidants (Basel).2024, 13(8):951.
  • ACS Omega.2022, 7(44):40009-40020.
  • Acta Pharm Sin B.2024, 14(4):1772-1786.
  • Journal of Food and Drug Analysis2023, 31(3), 9.
  • Phytomedicine.2017, 24:77-86
  • Plants (Basel).2024, 13(23):3314.
  • Oleocanthal

    Catalog No: CFN70331
    CAS No: 289030-99-5
    Price: Inquiry(manager@chemfaces.com)
    Zeaxanthin

    Catalog No: CFN90234
    CAS No: 144-68-3
    Price: Inquiry(manager@chemfaces.com)
    Inotodiol

    Catalog No: CFN92367
    CAS No: 35963-37-2
    Price: $338/5mg
    Notoginsenoside T5

    Catalog No: CFN92824
    CAS No: 769932-34-5
    Price: Inquiry(manager@chemfaces.com)
    Aloin B

    Catalog No: CFN90434
    CAS No: 28371-16-6
    Price: $138/20mg
    Research communications in chemical pathology and pharmacology, 1987, 56(2):265-272.
    Some biological effects of calvatic acid and its analog on isolated hepatocytes.[Reference: WebLink]
    Calvatic acid is a new antibiotic with both a carboxylic group and an azoxy function in the benzene ring.
    METHODS AND RESULTS:
    The relationship between structure and biological activity in this substance and one of its analog, phenylazoxyxyanide, was investigated. Isolated hepatocytes were used as an experimental system: the release of lactate dehydrogenase and the colchicine-binding activity of tubulin were first evaluated; effects were dose and time dependent. micromolar concentrations of these drugs determined a significant decrease of the glucose-6-phosphatase activity and a slight inhibition of aminopyrene demethylation.
    CONCLUSIONS:
    A toxic effect at the microsomal level and an interaction with the microtubular system are thus possible.
    Cell Biochemistry & Function, 1995, 13(4):231-238.
    Antimicrotubular effect of calvatic acid and of some related compounds.[Reference: WebLink]

    METHODS AND RESULTS:
    A structure–activity relationship has been established between Calvatic acid and some related synthetic compounds, and their ability to inhibit GTP‐induced microtubular protein polymerization in vitro. These compounds were effective in a dose‐ and a time‐dependent manner. The most active drug was the p‐chloro substituted compound, which showed its inhibitory activity without any preincubation period, which the others needed.
    CONCLUSIONS:
    Since if cysteine was present, polymerization was no longer affected, an involvement of titratable –SH groups of tubulin could be suggested. In contrast, taxol‐induced polymerization was only slightly inhibited by these compounds, and colchicine‐binding activity was not generally impaired.
    Verbasoside

    Catalog No: CFN95015
    CAS No: 61548-34-3
    Price: $318/5mg
    3,4-O-dimethylcedrusin

    Catalog No: CFN95026
    CAS No: 166021-14-3
    Price: $388/10mg
    Iristectorin A

    Catalog No: CFN95037
    CAS No: 37744-61-9
    Price: $318/20mg
    Carasinol B

    Catalog No: CFN95042
    CAS No: 777857-86-0
    Price: $333/5mg
    Lonicerin

    Catalog No: CFN95055
    CAS No: 25694-72-8
    Price: $168/10mg
    Cassiaside C

    Catalog No: CFN95120
    CAS No: 119170-52-4
    Price: $318/10mg
    Pueroside C

    Catalog No: CFN95156
    CAS No: 112343-16-5
    Price: $368/5mg
    4-Hydroxybenzoyl choline

    Catalog No: CFN95158
    CAS No: 5094-31-5
    Price: $318/20mg
    3-Acetyl-ginsenoside F1

    Catalog No: CFN95238
    CAS No: 1881225-08-6
    Price: $318/5mg
    7-O-(4-beta-D-glucopyranosyloxy-3-methoxybenzoyl)secologanolic acid

    Catalog No: CFN95365
    CAS No: 469899-55-6
    Price: $368/5mg